Literature DB >> 29138292

Impact of Regionalization of ST-Segment-Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services-Transported Patients Presenting to Hospitals With Percutaneous Coronary Intervention: Mission: Lifeline Accelerator-2.

James G Jollis1,2, Hussein R Al-Khalidi1, Mayme L Roettig3, Peter B Berger, Claire C Corbett4, Shannon M Doerfler1, Christopher B Fordyce5, Timothy D Henry6, Lori Hollowell, Zainab Magdon-Ismail7, Ajar Kochar1, James J McCarthy8, Lisa Monk1, Peter O'Brien9, Thomas D Rea10, Jay Shavadia1, Jacqueline Tamis-Holland11, B Hadley Wilson12, Khaled M Ziada13, Christopher B Granger1.   

Abstract

BACKGROUND: Regional variations in reperfusion times and mortality in patients with ST-segment-elevation myocardial infarction are influenced by differences in coordinating care between emergency medical services (EMS) and hospitals. Building on the Accelerator-1 Project, we hypothesized that time to reperfusion could be further reduced with enhanced regional efforts.
METHODS: Between April 2015 and March 2017, we worked with 12 metropolitan regions across the United States with 132 percutaneous coronary intervention-capable hospitals and 946 EMS agencies. Data were collected in the ACTION (Acute Coronary Treatment and Intervention Outcomes Network)-Get With The Guidelines Registry for quarterly Mission: Lifeline reports. The primary end point was the change in the proportion of EMS-transported patients with first medical contact to device time ≤90 minutes from baseline to final quarter. We also compared treatment times and mortality with patients treated in hospitals not participating in the project during the corresponding time period.
RESULTS: During the study period, 10 730 patients were transported to percutaneous coronary intervention-capable hospitals, including 974 in the baseline quarter and 972 in the final quarter who met inclusion criteria. Median age was 61 years; 27% were women, 6% had cardiac arrest, and 6% had shock on admission; 10% were black, 12% were Latino, and 10% were uninsured. By the end of the intervention, all process measures reflecting coordination between EMS and hospitals had improved, including the proportion of patients with a first medical contact to device time of ≤90 minutes (67%-74%; P<0.002), a first medical contact to device time to catheterization laboratory activation of ≤20 minutes (38%-56%; P<0.0001), and emergency department dwell time of ≤20 minutes (33%-43%; P<0.0001). Of the 12 regions, 9 regions reduced first medical contact to device time, and 8 met or exceeded the national goal of 75% of patients treated in ≤90 minutes. Improvements in treatment times corresponded with a significant reduction in mortality (in-hospital death, 4.4%-2.3%; P=0.001) that was not apparent in hospitals not participating in the project during the same time period.
CONCLUSIONS: Organization of care among EMS and hospitals in 12 regions was associated with significant reductions in time to reperfusion in patients with ST-segment-elevation myocardial infarction as well as in in-hospital mortality. These findings support a more intensive regional approach to emergency care for patients with ST-segment-elevation myocardial infarction.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  emergency medical services; health policy; myocardial infarction; outcome assessment (health care); percutaneous coronary intervention

Mesh:

Year:  2017        PMID: 29138292     DOI: 10.1161/CIRCULATIONAHA.117.032446

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  25 in total

1.  Emergency Department Telemedicine Consults are Associated with Faster Time-to-Electrocardiogram and Time-to-Fibrinolysis for Myocardial Infarction Patients.

Authors:  Aspen C Miller; Marcia M Ward; Fred Ullrich; Kimberly A S Merchant; Morgan B Swanson; Nicholas M Mohr
Journal:  Telemed J E Health       Date:  2020-02-28       Impact factor: 3.536

2.  How to Better Value EMS Clinicians as Key Care Team Members.

Authors:  Andrew J Torres; Rozalina G McCoy
Journal:  AMA J Ethics       Date:  2022-09-01

3.  Association of Cardiac Care Regionalization With Access, Treatment, and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction.

Authors:  Yu-Chu Shen; Harlan Krumholz; Renee Y Hsia
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2021-03-01

4.  Differential benefits of cardiac care regionalization based on driving time to percutaneous coronary intervention.

Authors:  Yu-Chu Shen; Renee Y Hsia
Journal:  Acad Emerg Med       Date:  2021-03-29       Impact factor: 3.451

5.  Impact of emergency medical service delays on time to reperfusion and mortality in STEMI.

Authors:  Ahmad Alrawashdeh; Ziad Nehme; Brett Williams; Karen Smith; Angela Brennan; Diem T Dinh; Danny Liew; Jeffrey Lefkovits; Dion Stub
Journal:  Open Heart       Date:  2021-05

6.  Surgeon Factors Have a Larger Effect on Vascular Access Type and Outcomes than Patient Factors.

Authors:  Timothy P Copeland; Peter F Lawrence; Karen Woo
Journal:  J Surg Res       Date:  2021-04-18       Impact factor: 2.417

7.  ECG pre-hospital teletransmission by emergency teams staffed with an emergency physician and paramedics and its impact on transportation and hospital admission.

Authors:  Joanna Sowizdraniuk; Jacek Smereka; Jerzy Robert Ladny; Alexander Kaserer; Krzysztof Palimonka; Kurt Ruetzler; Agnieszka Skierczynska; Lukasz Szarpak
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.889

Review 8.  [Cardiac arrest under special circumstances].

Authors:  Carsten Lott; Anatolij Truhlář; Anette Alfonzo; Alessandro Barelli; Violeta González-Salvado; Jochen Hinkelbein; Jerry P Nolan; Peter Paal; Gavin D Perkins; Karl-Christian Thies; Joyce Yeung; David A Zideman; Jasmeet Soar
Journal:  Notf Rett Med       Date:  2021-06-10       Impact factor: 0.826

Review 9.  Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association.

Authors:  Abdulla A Damluji; Sean van Diepen; Jason N Katz; Venu Menon; Jacqueline E Tamis-Holland; Marie Bakitas; Mauricio G Cohen; Leora B Balsam; Joanna Chikwe
Journal:  Circulation       Date:  2021-06-15       Impact factor: 39.918

10.  Preclinical Studies of RUC-4, a Novel Platelet αIIbβ3 Antagonist, in Non-Human Primates and With Human Platelets.

Authors:  Spandana Vootukuri; Jihong Li; Mark Nedelman; Craig Thomas; Jiang-Kang Jiang; Mariana Babayeva; Barry S Coller
Journal:  J Clin Transl Sci       Date:  2019-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.